Search

Search Results

• A Rare Case of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

  Anastasiya Gennadevna Kolgotina, L.A. Kramynin, I.V. Ishmatova, L.V. Filatova, P.A. Sapronov, M.V. Grinkevich, A.L. Muravtseva, I.S. Zyuzgin

  277-285

  01.07.2025

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Complicated by Dialysis-Dependent Renal Failure

  Ekaterina Alekseevna Karimova, E.I. Zhelnova, E.A. Baryakh, E.Yu. Grishina, E.N. Zotina, D.E. Gagloeva, V.N. Yakimets, O.L. Kochneva, E.N. Misyurina

  171-176

  01.04.2025

• Anti-CD38 Antibodies in Monotherapy for Patients with Relapsed/Refractory Multiple Myeloma: Real-World Clinical Practice and Results of Clinical Trials

  Margarita Andreevna Ulyanova, V.I. Vorobyev, L.A. Bychenkova, S.V. Semochkin

  145-152

  01.04.2025

• The Efficacy of Bortezomib, Lenalidomide, and Dexamethasone Combination as Induction Therapy in Patients with Multiple Myeloma Complicated by the End-Stage Renal Disease

  Sergei Vyacheslavovich Semochkin, E.I. Zhelnova, V.I. Kazey, A.V. Cherkasova, A.G. Nikiforova, N.F. Frolova, E.A. Baryakh, K.V. Yatskov, E.A. Karimova, O.N. Kotenko, E.N. Misyurina

  360-369

  01.10.2024

• Comparative Efficacy of Autologous Hematopoietic Stem Cell Mobilization Regimens in Multiple Myeloma Patients

  Ivan Ivanovich Kostroma, Zh.V. Chubukina, V.A. Yudina, N.A. Romanenko, E.I. Stepchenkova, S.S. Bessmeltsev, S.V. Sidorkevich, S.V. Gritsaev

  43-49

  17.05.2024

• Treatment of Aggressive Systemic Mastocytosis and Mast Cell Leukemia. Literature Review and Case Reports

  Vsevolod Gennadevich Potapenko, E.V. Morozova

  180-194

  01.04.2024

• Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  229-241

  09.06.2023

• Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

  I.G. Rekhtina, Viktoriya Aleksandrovna Khyshova, M.V. Solov’ev, L.P. Mendeleeva

  166-173

  03.03.2023

• Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study

  T.I. Ionova, O.Yu. Vinogradova, Yu.B. Kochkareva, E.E. Markova, K.D. Kaplanov, M.N. Shirokova, T.V. Shelekhova, A.N. Levanov, A.V. Kopylova, O.Yu. Li, T.A. Mitina, O.A. Rukavitsyn, P.I. Simashova, L.V. Anchukova, E.N. Babich, S.A. Volkova, D.B. Dasheeva, M.V. Demchenkova, S.K. Dubov, T.V. Esenina, L.E. Ivanova, T.L. Kravchuk, E.V. Rimashevskaya, M.T. Savinova, N.O. Saraeva, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin

  240-252

  01.07.2022

• Mantle Cell Lymphoma: History, Current Principles of Diagnosis, and Treatment (Literature Review)

  Gayane Sepugovna Tumyan

  366-381

  01.10.2020

• Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Treatment with and without the Use of Granulocyte Colony-Stimulating Factor in Post-Transplantation Period

  S.V. Gritsaev, Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, V.N. Chebotkevich, S.S. Bessmeltsev, A.V. Chechetkin

  289-294

  01.07.2020

• Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

  Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya

  25-32

  01.01.2020

• Infectious Complications in Multiple Myeloma Patients Receiving Various Antitumor Regimens

  Anna Aleksandrovna Novikova, G.A. Klyasova, E.O. Gribanova, V.V. Ryzhko, T.A. Tupoleva, L.P. Mendeleeva, V.G. Savchenko

  231-239

  01.04.2019

• Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

  Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev, K.D. Kaplanov

  21-31

  01.01.2019

• Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

  Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko

  360-367

  01.10.2018

• Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, Zh.V. Chubukina, I.M. Zapreeva, S.A. Tiranova, A.V. Sel’tser, N.Yu. Semenova, S.S. Bessmel’tsev, A.V. Chechetkin, S.V. Gritsaev

  192-197

  01.04.2018

• New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

  Ol’ga Mikhailovna Votyakova

  425-434

  01.10.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Elotuzumab for Treatment of Multiple Myeloma (Literature Review)

  Ol’ga Mikhailovna Votyakova

  438-445

  01.10.2016

• Pomalidomide for Treatment of Relapsed and Refractory Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  379-389

  01.10.2015

• Role of Bendamustine in Treatment of Multiple Myeloma

  O.M. Votyakova

  301-310

  01.07.2014

• Management of relapsed and refractory multiple myeloma: literature review and our data. Part III

  S.S. Bessmeltsev

  137-174

  01.04.2014

• Multiple myeloma (management of newly diagnosed patients): literature review and our on data. Part II

  S.S. Bessmeltsev

  379-414

  01.10.2013